1. Show article details.

    HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cronos Group Inc. (CRON) Investors to Contact Firm’s Attorneys, Firm Investigating Cronos’ Admitted Improper Accounting

    GlobeNewswire – 5:14 PM ET 11/30/2021

    Hagens Berman urges Cronos Group Inc. (CRON) investors with significant losses to submit your losses now. Cronos Group Inc. Investigation: In past quarters Cronos (CRON) has maintained it reports its financial results in accordance with Generally Accepted Accounting Principles, including for its goodwill valuations and making timely impairment charges.

  2. Show article details.

    CRONOS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cronos Group Inc. on Behalf of Cronos Stockholders and Encourages Investors to Contact the Firm

    GlobeNewswire – 5:00 AM ET 11/27/2021

    Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cronos Group Inc. (CRON) on behalf of Cronos (CRON) stockholders. Click here to participate in the action.

  3. Show article details.

    HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cronos Group Inc. (CRON) Investors to Contact Firm’s Attorneys, Firm Investigating Cronos’ Admitted Improper Accounting

    GlobeNewswire – 4:31 PM ET 11/23/2021

    Hagens Berman urges Cronos Group Inc. (CRON) investors with significant losses to submit your losses now.

  4. Show article details.

    Beatrice Society Forms Board of Directors

    Business Wire – 8:00 AM ET 11/22/2021

    Gary Yeoman to Serve as Chairman Beatrice Society, a psychedelics and functional mushroom company focused on improving psychotherapy-driven patient outcomes and everyday quality of life, today announced the formation of its initial Board of Directors, including a new Chairman.

  5. Show article details.

    BRIEF-Cronos Group Announces Receipt Of Nasdaq Listing Delinquency Letter

    Reuters – 5:24 PM ET 11/19/2021

    Cronos Group Inc (CRON): * CRONOS GROUP PROVIDES BI-WEEKLY MCTO STATUS UPDATE AND ANNOUNCES RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER. * Cronos Group Inc (CRON) - COMPANY'S MANAGEMENT CONTINUES TO WORK TO COMPLETE REQUIRED FILINGS Source text for Eikon: Further company coverage:

  6. Show article details.

    Cronos Group Provides Bi-Weekly MCTO Status Update and Announces Receipt of Nasdaq Listing Delinquency Letter

    GlobeNewswire – 4:30 PM ET 11/19/2021

    Cronos Group Inc. (CRON) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders and disclosing receipt of a Nasdaq Listing delinquency letter.

  7. Show article details.

    CANADA STOCKS-TSX closes slightly lower on U.S. cannabis concerns, gold decline

    Reuters – 4:40 PM ET 11/18/2021

    * TSX ends down 15.48 points, or 0.07%, at 21,637.54. * Cannabis firms fall on Barclays report, U.S. legalization doubts. * Basic materials follow gold lower. By Nichola Saminather. Canada's main stock index closed marginally lower on Thursday, as steep declines in cannabis stocks were offset by gains in industrials, technology and energy stocks.

  8. Show article details.

    CRONOS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cronos Group Inc. on Behalf of Cronos Stockholders and Encourages Investors to Contact the Firm

    Business Wire – 10:00 PM ET 11/17/2021

    Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cronos Group Inc. (CRON) on behalf of Cronos (CRON) stockholders. Click here to participate in the action.

  9. Show article details.

    HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cronos Group Inc. (CRON) Investors to Contact Firm’s Attorneys, Firm Investigating Cronos’ Admitted Improper Accounting

    GlobeNewswire – 5:27 PM ET 11/15/2021

    Hagens Berman urges Cronos Group Inc. (CRON) investors with significant losses to submit your losses now.

  10. Show article details.

    CRONOS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cronos Group Inc. on Behalf of Cronos Stockholders and Encourages Investors to Contact the Firm

    Business Wire – 9:00 PM ET 11/12/2021

    Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cronos Group Inc. (CRON) on behalf of Cronos (CRON) stockholders. Click here to participate in the action.

  11. Show article details.

    CANADA STOCKS-TSX closes just shy of record as mining stocks ride gold wave

    Reuters – 4:32 PM ET 11/11/2021

    * TSX ends up 120.05 points, or 0.56%, at 21,581.98. * Materials index adds 2.6% as gold hits five-month high. * Cannabis stocks gain as analysts lift Aurora target price. By Nichola Saminather. Canada's main stock index closed just shy of this week's record high on Thursday, led by mining shares that received a boost from stronger gold prices as investors sought refuge from surging inflation.

  12. Show article details.

    HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cronos Group Inc. (CRON) Investors to Contact Firm's Attorneys, Firm Investigating Cronos' Admitted Improper Accounting

    PR Newswire – 4:38 PM ET 11/10/2021

    SAN FRANCISCO, Nov. 10, 2021 Hagens Berman urges Cronos Group Inc. (CRON)  investors with significant losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/CRON.

  13. Show article details.

    HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cronos Group Inc. (CRON) Investors to Contact Firm’s Attorneys, Firm Investigating Cronos’ Admitted Improper Accounting

    GlobeNewswire – 7:34 PM ET 11/09/2021

    Hagens Berman urges Cronos Group Inc. (CRON) investors with significant losses to submit your losses now. Cronos Group Inc. Investigation: In past quarters Cronos (CRON) has maintained it reports its financial results in accordance with Generally Accepted Accounting Principles, including for its goodwill valuations and making timely impairment charges.

  14. Show article details.

    CANADA STOCKS-TSX retreats from record closing peak as healthcare stocks slip

    Reuters – 10:01 AM ET 11/09/2021

    Canada's main stock index took a breather on Tuesday after hitting a new closing high in the previous session, dragged down by weakness in healthcare stocks, while investors remained cautious ahead of a reading on U.S. inflation later this week. At 9:54 a.m. ET, the Toronto Stock Exchange's S&P/TSX composite index was down 34.31 points, or 0.16%, at 21,546.78, snapping its four-day winning streak.

  15. Show article details.

    BRIEF-Cronos Group Determined It Will Be Required To Restate Interim Financial Statements For 3 & 6 Months Ended June 30, 2021

    Reuters – 7:44 AM ET 11/09/2021

    Cronos Group Inc (CRON): * CRONOS GROUP (CRON) - DETERMINED IT WILL BE REQUIRED TO RESTATE PREVIOUSLY ISSUED UNAUDITED INTERIM FINANCIAL STATEMENTS FOR 3 & 6 MONTHS ENDED JUNE 30, 2021. * CRONOS GROUP (CRON) - UNAUDITED INTERIM FINANCIAL STATEMENTS FOR THREE AND SIX MONTHS ENDED JUNE 30, 2021 WERE PREVIOUSLY FILED ON FORM 10-Q ON AUGUST 6, 2021.

  16. Show article details.

    Cronos Group Files Form 12b-25

    GlobeNewswire – 7:30 AM ET 11/09/2021

    Cronos Group Inc. (CRON) today announced that it has filed a Form 12b-25 with the U.S. Securities and Exchange Commission in connection with its Quarterly Report on Form 10-Q for the period ended September 30, 2021.

  17. Show article details.

    CANADA STOCKS-Canada's TSX hits 3rd straight record on U.S. cannabis report, global sentiment

    Reuters – 4:43 PM ET 11/08/2021

    * TSX ends up 100.72 points, or 0.5%, at 21,556.54. * Cannabis stocks are top five gainers on index. * Energy, materials sectors up 1.2% By Nichola Saminather.

  18. Show article details.

    CANADA STOCKS-Healthcare, commodity-linked stocks lift TSX to record high

    Reuters – 10:06 AM ET 11/08/2021

    Canada's main stock index hit a record high on Monday, aided by gains in healthcare and commodity-linked stocks, with sentiment getting a boost from the passage of a $1 trillion U.S. infrastructure bill.

  19. Show article details.

    BRIEF-Cronos Group Chief Innovation Officer Todd Abraham To Retire

    Reuters – 7:48 AM ET 10/29/2021

    Cronos Group Inc (CRON): * CRONOS GROUP CHIEF INNOVATION OFFICER DR. TODD ABRAHAM TO RETIRE Source text for Eikon: Further company coverage:

  20. Show article details.

    Cronos Group Chief Innovation Officer Dr. Todd Abraham to Retire

    GlobeNewswire – 7:30 AM ET 10/29/2021

    Arye Weigensberg Named Interim Head of Research and Development Search to Identify Permanent Successor Well Underway Cronos Group Inc. (CRON), an innovative global cannabinoid company, today announced that Dr. Todd Abraham will retire as Chief Innovation Officer, after a distinguished 40-year career, including the last two years at Cronos Group.

Page:

Today's and Upcoming Events

  • Dec
    01

    CRON to announce Q3 earnings (Unconfirmed)

Past Events (last 90 days)

No events in the past 90 days

Data provided by Thomson Reuters © 2021

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.